JCB logo
Accuri Cytometers
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online April 7, 2008
doi:10.1083/jcb.200710038
The Journal of Cell Biology, Vol. 181, No. 1, 43-50
The Rockefeller University Press, 0021-9525 $30.00
© 2008 Weis et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 4472K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weis, S. M.
Right arrow Articles by Cheresh, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weis, S. M.
Right arrow Articles by Cheresh, D. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Report

Compensatory role for Pyk2 during angiogenesis in adult mice lacking endothelial cell FAK



Sara M. Weis1, Ssang-Taek Lim1, Kimberly M. Lutu-Fuga1, Leo A. Barnes1, Xiao Lei Chen1, Joachim R. Göthert4, Tang-Long Shen5,6, Jun-Lin Guan4,5, David D. Schlaepfer1,2, and David A. Cheresh1,3

1 Moores UCSD Cancer Center, 2 Department of Reproductive Medicine, and 3 Department of Pathology, University of California, San Diego, La Jolla, CA 92093
4 Department of Hematology, University Hospital of Essen, Essen 45122, Germany
5 Department of Internal Medicine and 6 Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI 48109

Correspondence to D.A. Cheresh: dcheresh{at}ucsd.edu

Focal adhesion kinase (FAK) plays a critical role during vascular development because knockout of FAK in endothelial cells (ECs) is embryonic lethal. Surprisingly, tamoxifen-inducible conditional knockout of FAK in adult blood vessels (inducible EC–specific FAK knockout [i-EC-FAK-KO]) produces no vascular phenotype, and these animals are capable of developing a robust growth factor–induced angiogenic response. Although angiogenesis in wild-type mice is suppressed by pharmacological inhibition of FAK, i-EC-FAK-KO mice are refractory to this treatment, which suggests that adult i-EC-FAK-KO mice develop a compensatory mechanism to bypass the requirement for FAK. Indeed, expression of the FAK-related proline-rich tyrosine kinase 2 (Pyk2) is elevated and phosphorylated in i-EC-FAK-KO blood vessels. In cultured ECs, FAK knockdown leads to increased Pyk2 expression and, surprisingly, FAK kinase inhibition leads to increased Pyk2 phosphorylation. Pyk2 can functionally compensate for the loss of FAK because knockdown or pharmacological inhibition of Pyk2 disrupts angiogenesis in i-EC-FAK-KO mice. These studies reveal the adaptive capacity of ECs to switch to Pyk2-dependent signaling after deletion or kinase inhibition of FAK.

Abbreviations used in this paper: BAEC, bovine aortic endothelial cell; bFGF, basic fibroblast growth factor; EC, endothelial cell; HUVEC, human umbilical vein endothelial cell; i-EC-FAK-KO, inducible EC–specific FAK knockout; Pyk2, proline-rich tyrosine kinase 2; shRNA, short hairpin RNA; WT, wild type.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents